- IBDEI3GT ; ; 19-NOV-2015
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,58282,1,4,0)
- ;;=4^E08.319
- ;;^UTILITY(U,$J,358.3,58282,2)
- ;;=^5002511
- ;;^UTILITY(U,$J,358.3,58283,0)
- ;;=E08.321^^272^2905^35
- ;;^UTILITY(U,$J,358.3,58283,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58283,1,3,0)
- ;;=3^Diab d/t Undrl Cond w/ Mild Nonprolif Diab Retinopathy w/ Macular Edema
- ;;^UTILITY(U,$J,358.3,58283,1,4,0)
- ;;=4^E08.321
- ;;^UTILITY(U,$J,358.3,58283,2)
- ;;=^5002512
- ;;^UTILITY(U,$J,358.3,58284,0)
- ;;=E08.329^^272^2905^36
- ;;^UTILITY(U,$J,358.3,58284,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58284,1,3,0)
- ;;=3^Diab d/t Undrl Cond w/ Mild Nonprolif Diab Retinopathy w/o Macular Edema
- ;;^UTILITY(U,$J,358.3,58284,1,4,0)
- ;;=4^E08.329
- ;;^UTILITY(U,$J,358.3,58284,2)
- ;;=^5002513
- ;;^UTILITY(U,$J,358.3,58285,0)
- ;;=E08.331^^272^2905^37
- ;;^UTILITY(U,$J,358.3,58285,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58285,1,3,0)
- ;;=3^Diab d/t Undrl Cond w/ Moderate Nonprolif Diab Retinopathy w/ Macular Edema
- ;;^UTILITY(U,$J,358.3,58285,1,4,0)
- ;;=4^E08.331
- ;;^UTILITY(U,$J,358.3,58285,2)
- ;;=^5002514
- ;;^UTILITY(U,$J,358.3,58286,0)
- ;;=E08.339^^272^2905^38
- ;;^UTILITY(U,$J,358.3,58286,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58286,1,3,0)
- ;;=3^Diab d/t Undrl Cond w/ Moderate Nonprolif Diab Retinopathy w/o Macular Edema
- ;;^UTILITY(U,$J,358.3,58286,1,4,0)
- ;;=4^E08.339
- ;;^UTILITY(U,$J,358.3,58286,2)
- ;;=^5002515
- ;;^UTILITY(U,$J,358.3,58287,0)
- ;;=E08.341^^272^2905^39
- ;;^UTILITY(U,$J,358.3,58287,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58287,1,3,0)
- ;;=3^Diab d/t Undrl Cond w/ Severe Nonprolif Diab Retinopathy w/ Macular Edema
- ;;^UTILITY(U,$J,358.3,58287,1,4,0)
- ;;=4^E08.341
- ;;^UTILITY(U,$J,358.3,58287,2)
- ;;=^5002516
- ;;^UTILITY(U,$J,358.3,58288,0)
- ;;=E08.349^^272^2905^40
- ;;^UTILITY(U,$J,358.3,58288,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58288,1,3,0)
- ;;=3^Diab d/t Undrl Cond w/ Severe Nonprolif Diab Retinopathy w/o Macular Edema
- ;;^UTILITY(U,$J,358.3,58288,1,4,0)
- ;;=4^E08.349
- ;;^UTILITY(U,$J,358.3,58288,2)
- ;;=^5002517
- ;;^UTILITY(U,$J,358.3,58289,0)
- ;;=E09.311^^272^2905^31
- ;;^UTILITY(U,$J,358.3,58289,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58289,1,3,0)
- ;;=3^Diab d/t Drug/Chem w/ Unspec Diab Retinopathy w/ Macular Edema
- ;;^UTILITY(U,$J,358.3,58289,1,4,0)
- ;;=4^E09.311
- ;;^UTILITY(U,$J,358.3,58289,2)
- ;;=^5002552
- ;;^UTILITY(U,$J,358.3,58290,0)
- ;;=E09.319^^272^2905^32
- ;;^UTILITY(U,$J,358.3,58290,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58290,1,3,0)
- ;;=3^Diab d/t Drug/Chem w/ Unspec Diab Retinopathy w/o Macular Edema
- ;;^UTILITY(U,$J,358.3,58290,1,4,0)
- ;;=4^E09.319
- ;;^UTILITY(U,$J,358.3,58290,2)
- ;;=^5002553
- ;;^UTILITY(U,$J,358.3,58291,0)
- ;;=E09.321^^272^2905^27
- ;;^UTILITY(U,$J,358.3,58291,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58291,1,3,0)
- ;;=3^Diab d/t Drug/Chem w/ Mild Nonprolif Diab Retinopathy w/ Macular Edema
- ;;^UTILITY(U,$J,358.3,58291,1,4,0)
- ;;=4^E09.321
- ;;^UTILITY(U,$J,358.3,58291,2)
- ;;=^5002554
- ;;^UTILITY(U,$J,358.3,58292,0)
- ;;=E09.329^^272^2905^28
- ;;^UTILITY(U,$J,358.3,58292,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58292,1,3,0)
- ;;=3^Diab d/t Drug/Chem w/ Mild Nonprolif Diab Retinopathy w/o Macular Edema
- ;;^UTILITY(U,$J,358.3,58292,1,4,0)
- ;;=4^E09.329
- ;;^UTILITY(U,$J,358.3,58292,2)
- ;;=^5002555
- ;;^UTILITY(U,$J,358.3,58293,0)
- ;;=E09.351^^272^2905^29
- ;;^UTILITY(U,$J,358.3,58293,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58293,1,3,0)
- ;;=3^Diab d/t Drug/Chem w/ Prolif Diab Retinopathy w/ Macular Edema
- ;;^UTILITY(U,$J,358.3,58293,1,4,0)
- ;;=4^E09.351
- ;;^UTILITY(U,$J,358.3,58293,2)
- ;;=^5002560
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3GT 3950 printed Feb 19, 2025@00:14:55 Page 2
- IBDEI3GT ; ; 19-NOV-2015
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,99)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,58282,1,4,0)
- +2 ;;=4^E08.319
- +3 ;;^UTILITY(U,$J,358.3,58282,2)
- +4 ;;=^5002511
- +5 ;;^UTILITY(U,$J,358.3,58283,0)
- +6 ;;=E08.321^^272^2905^35
- +7 ;;^UTILITY(U,$J,358.3,58283,1,0)
- +8 ;;=^358.31IA^4^2
- +9 ;;^UTILITY(U,$J,358.3,58283,1,3,0)
- +10 ;;=3^Diab d/t Undrl Cond w/ Mild Nonprolif Diab Retinopathy w/ Macular Edema
- +11 ;;^UTILITY(U,$J,358.3,58283,1,4,0)
- +12 ;;=4^E08.321
- +13 ;;^UTILITY(U,$J,358.3,58283,2)
- +14 ;;=^5002512
- +15 ;;^UTILITY(U,$J,358.3,58284,0)
- +16 ;;=E08.329^^272^2905^36
- +17 ;;^UTILITY(U,$J,358.3,58284,1,0)
- +18 ;;=^358.31IA^4^2
- +19 ;;^UTILITY(U,$J,358.3,58284,1,3,0)
- +20 ;;=3^Diab d/t Undrl Cond w/ Mild Nonprolif Diab Retinopathy w/o Macular Edema
- +21 ;;^UTILITY(U,$J,358.3,58284,1,4,0)
- +22 ;;=4^E08.329
- +23 ;;^UTILITY(U,$J,358.3,58284,2)
- +24 ;;=^5002513
- +25 ;;^UTILITY(U,$J,358.3,58285,0)
- +26 ;;=E08.331^^272^2905^37
- +27 ;;^UTILITY(U,$J,358.3,58285,1,0)
- +28 ;;=^358.31IA^4^2
- +29 ;;^UTILITY(U,$J,358.3,58285,1,3,0)
- +30 ;;=3^Diab d/t Undrl Cond w/ Moderate Nonprolif Diab Retinopathy w/ Macular Edema
- +31 ;;^UTILITY(U,$J,358.3,58285,1,4,0)
- +32 ;;=4^E08.331
- +33 ;;^UTILITY(U,$J,358.3,58285,2)
- +34 ;;=^5002514
- +35 ;;^UTILITY(U,$J,358.3,58286,0)
- +36 ;;=E08.339^^272^2905^38
- +37 ;;^UTILITY(U,$J,358.3,58286,1,0)
- +38 ;;=^358.31IA^4^2
- +39 ;;^UTILITY(U,$J,358.3,58286,1,3,0)
- +40 ;;=3^Diab d/t Undrl Cond w/ Moderate Nonprolif Diab Retinopathy w/o Macular Edema
- +41 ;;^UTILITY(U,$J,358.3,58286,1,4,0)
- +42 ;;=4^E08.339
- +43 ;;^UTILITY(U,$J,358.3,58286,2)
- +44 ;;=^5002515
- +45 ;;^UTILITY(U,$J,358.3,58287,0)
- +46 ;;=E08.341^^272^2905^39
- +47 ;;^UTILITY(U,$J,358.3,58287,1,0)
- +48 ;;=^358.31IA^4^2
- +49 ;;^UTILITY(U,$J,358.3,58287,1,3,0)
- +50 ;;=3^Diab d/t Undrl Cond w/ Severe Nonprolif Diab Retinopathy w/ Macular Edema
- +51 ;;^UTILITY(U,$J,358.3,58287,1,4,0)
- +52 ;;=4^E08.341
- +53 ;;^UTILITY(U,$J,358.3,58287,2)
- +54 ;;=^5002516
- +55 ;;^UTILITY(U,$J,358.3,58288,0)
- +56 ;;=E08.349^^272^2905^40
- +57 ;;^UTILITY(U,$J,358.3,58288,1,0)
- +58 ;;=^358.31IA^4^2
- +59 ;;^UTILITY(U,$J,358.3,58288,1,3,0)
- +60 ;;=3^Diab d/t Undrl Cond w/ Severe Nonprolif Diab Retinopathy w/o Macular Edema
- +61 ;;^UTILITY(U,$J,358.3,58288,1,4,0)
- +62 ;;=4^E08.349
- +63 ;;^UTILITY(U,$J,358.3,58288,2)
- +64 ;;=^5002517
- +65 ;;^UTILITY(U,$J,358.3,58289,0)
- +66 ;;=E09.311^^272^2905^31
- +67 ;;^UTILITY(U,$J,358.3,58289,1,0)
- +68 ;;=^358.31IA^4^2
- +69 ;;^UTILITY(U,$J,358.3,58289,1,3,0)
- +70 ;;=3^Diab d/t Drug/Chem w/ Unspec Diab Retinopathy w/ Macular Edema
- +71 ;;^UTILITY(U,$J,358.3,58289,1,4,0)
- +72 ;;=4^E09.311
- +73 ;;^UTILITY(U,$J,358.3,58289,2)
- +74 ;;=^5002552
- +75 ;;^UTILITY(U,$J,358.3,58290,0)
- +76 ;;=E09.319^^272^2905^32
- +77 ;;^UTILITY(U,$J,358.3,58290,1,0)
- +78 ;;=^358.31IA^4^2
- +79 ;;^UTILITY(U,$J,358.3,58290,1,3,0)
- +80 ;;=3^Diab d/t Drug/Chem w/ Unspec Diab Retinopathy w/o Macular Edema
- +81 ;;^UTILITY(U,$J,358.3,58290,1,4,0)
- +82 ;;=4^E09.319
- +83 ;;^UTILITY(U,$J,358.3,58290,2)
- +84 ;;=^5002553
- +85 ;;^UTILITY(U,$J,358.3,58291,0)
- +86 ;;=E09.321^^272^2905^27
- +87 ;;^UTILITY(U,$J,358.3,58291,1,0)
- +88 ;;=^358.31IA^4^2
- +89 ;;^UTILITY(U,$J,358.3,58291,1,3,0)
- +90 ;;=3^Diab d/t Drug/Chem w/ Mild Nonprolif Diab Retinopathy w/ Macular Edema
- +91 ;;^UTILITY(U,$J,358.3,58291,1,4,0)
- +92 ;;=4^E09.321
- +93 ;;^UTILITY(U,$J,358.3,58291,2)
- +94 ;;=^5002554
- +95 ;;^UTILITY(U,$J,358.3,58292,0)
- +96 ;;=E09.329^^272^2905^28
- +97 ;;^UTILITY(U,$J,358.3,58292,1,0)
- +98 ;;=^358.31IA^4^2
- +99 ;;^UTILITY(U,$J,358.3,58292,1,3,0)
- +100 ;;=3^Diab d/t Drug/Chem w/ Mild Nonprolif Diab Retinopathy w/o Macular Edema
- +101 ;;^UTILITY(U,$J,358.3,58292,1,4,0)
- +102 ;;=4^E09.329
- +103 ;;^UTILITY(U,$J,358.3,58292,2)
- +104 ;;=^5002555
- +105 ;;^UTILITY(U,$J,358.3,58293,0)
- +106 ;;=E09.351^^272^2905^29
- +107 ;;^UTILITY(U,$J,358.3,58293,1,0)
- +108 ;;=^358.31IA^4^2
- +109 ;;^UTILITY(U,$J,358.3,58293,1,3,0)
- +110 ;;=3^Diab d/t Drug/Chem w/ Prolif Diab Retinopathy w/ Macular Edema
- +111 ;;^UTILITY(U,$J,358.3,58293,1,4,0)
- +112 ;;=4^E09.351
- +113 ;;^UTILITY(U,$J,358.3,58293,2)
- +114 ;;=^5002560
